Karyopharm Therapeutics (KPTI) Q4 2025 Earnings

3NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-4.42
-3.87
-3.32
-2.77

Details

Expected EPS
-3.4655
Actual EPS
-3.82
Surprise EPS
-0.35
Surprise Percent
+10.23%

Description

Karyopharm Therapeutics (KPTI) has reported earnings of -3.82 per share for Q4 2025.

0 Comments

Share your thoughts